These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39021180)

  • 1. Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment.
    Scarfo S; Moshfeghi Y; J McGeown W
    Curr Alzheimer Res; 2024 Jul; ():. PubMed ID: 39021180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits.
    Wiels WA; Wittens MMJ; Zeeuws D; Baeken C; Engelborghs S
    Front Psychiatry; 2021; 12():707580. PubMed ID: 34483998
    [No Abstract]   [Full Text] [Related]  

  • 5. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    El Haffaf LM; Ronat L; Cannizzaro A; Hanganu A;
    J Alzheimers Dis; 2024; 97(2):841-853. PubMed ID: 38143342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile.
    Donaghy PC; Ciafone J; Durcan R; Hamilton CA; Barker S; Lloyd J; Firbank M; Allan LM; O'Brien JT; Taylor JP; Thomas AJ
    Psychol Med; 2022 Apr; 52(6):1147-1155. PubMed ID: 32840196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.
    Wadsworth LP; Lorius N; Donovan NJ; Locascio JJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    Dement Geriatr Cogn Disord; 2012; 34(2):96-111. PubMed ID: 22922821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
    Park JI;
    Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.
    Apostolova LG; Di LJ; Duffy EL; Brook J; Elashoff D; Tseng CH; Fairbanks L; Cummings JL
    Dement Geriatr Cogn Disord; 2014; 37(5-6):315-26. PubMed ID: 24481207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.
    De Vito AN; Calamia M; Weitzner DS; Bernstein JPK;
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1627-1634. PubMed ID: 30276884
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.